Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome

计划入组 5 人 · 首次发布于 2023 年 5 月 6 日

Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial

计划入组 320 人 · 首次发布于 2020 年 12 月 10 日

Phase I Study of Progerinin in Healthy Volunteers

计划入组 64 人 · 首次发布于 2020 年 8 月 14 日

Werner syndrome ATP dependent helicase inhibitor (cancer)

Werner inhibitor (MSI-high cancers/sensitive cancers)

cisplatin micelle

Michelle Kinney

United States

Dr Michelle Miller

Canada

CORPCLO 1982 CC

South Africa

Ipsen Names Michelle Werner as North America President to Drive Growth Strategy

Traws Pharma Announces Leadership Transition as CEO Werner Cautreels Retires

First Clinical Trial Shows Nicotinamide Riboside Improves Multiple Health Outcomes in Werner Syndrome Patients